PRR20B
gene geneOn this page
Summary
PRR20B (proline rich 20B, HGNC:37220) is a protein-coding gene on chromosome 13q21.1, encoding Proline-rich protein 20B (P86481).
This gene is one of five identical loci in a cluster on chromosome 13q21.1. The predicted protein is proline-rich and contains several dopamine D4 receptor signatures and PRINTS domains.
Source: NCBI Gene 729233 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_001130404
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37220 |
| Approved symbol | PRR20B |
| Name | proline rich 20B |
| Location | 13q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204918 |
| Ensembl biotype | protein_coding |
| Entrez | 729233 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000377930
RefSeq mRNA: 1 — MANE Select: NM_001130404
NM_001130404
CCDS: CCDS45053
Canonical transcript exons
ENST00000377930 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001696996 | 57147856 | 57147926 |
| ENSE00001790301 | 57148948 | 57150509 |
| ENSE00002627353 | 57147488 | 57147701 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 53.08.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 53.08 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.07 | gold quality |
| stromal cell of endometrium | CL:0002255 | 38.49 | gold quality |
| monocyte | CL:0000576 | 38.41 | gold quality |
| bone marrow cell | CL:0002092 | 38.04 | gold quality |
| leukocyte | CL:0000738 | 37.44 | gold quality |
| sural nerve | UBERON:0015488 | 37.37 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 36.77 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.02 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.27 | gold quality |
| muscle tissue | UBERON:0002385 | 33.00 | gold quality |
| bone marrow | UBERON:0002371 | 32.70 | gold quality |
| liver | UBERON:0002107 | 30.97 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.19 | gold quality |
| urinary bladder | UBERON:0001255 | 28.43 | gold quality |
| ectocervix | UBERON:0012249 | 28.38 | gold quality |
| blood | UBERON:0000178 | 28.28 | gold quality |
| right uterine tube | UBERON:0001302 | 28.23 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| calcaneal tendon | UBERON:0003701 | 28.11 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.28 | gold quality |
| uterine cervix | UBERON:0000002 | 27.23 | gold quality |
| right lobe of liver | UBERON:0001114 | 27.22 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
54 targeting PRR20B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-543 | 99.52 | 69.03 | 2595 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-302A-5P | 99.39 | 68.21 | 1913 |
| HSA-MIR-4796-5P | 99.34 | 70.06 | 810 |
| HSA-MIR-6128 | 99.33 | 67.83 | 1581 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-422A | 99.18 | 65.83 | 550 |
| HSA-MIR-146A-3P | 99.13 | 68.99 | 1881 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-4742-3P | 98.73 | 69.82 | 1803 |
Cross-species orthologs
0 orthologs
Paralogs (5): PRR20A (ENSG00000204919), PRR20D (ENSG00000227151), PRR20C (ENSG00000229665), PRR20E (ENSG00000234278), PRR20G (ENSG00000239620)
Protein
Protein identifiers
Proline-rich protein 20B — P86481 (reviewed: P86481)
All UniProt accessions (1): P86481
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the PRR20 family.
RefSeq proteins (1): NP_001123876* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031439 | PRR20 | Family |
Pfam: PF15708
UniProt features (6 total): compositionally biased region 3, region of interest 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P86481-F1 | 51.07 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
chr13q21, LET_7A_2_3P, LET_7G_3P, MIR5581_3P, MIR4714_5P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
BioGRID (498): PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid), PRR20A (Two-hybrid)
ESM2 similar proteins: A0A0U1RQG5, A1L429, A6NDE8, A6NER3, A6NGK3, E1AZ71, O08664, O60829, O75459, O76087, P0C2W7, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P52651, P62521, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q17QW4, Q28181, Q2T9P9, Q32PA2, Q4V321, Q4V326, Q5JQC4, Q5U2Y8, Q62100, Q63803, Q64256, Q6NT46, Q6X7S9, Q7Z2X7
Diamond homologs: P0DPQ3, P86478, P86479, P86480, P86481, P86496
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
430 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:57147699:CAG:C | donor_loss | 1.0000 |
| 13:57147701:GG:G | donor_loss | 1.0000 |
| 13:57147702:GT:G | donor_loss | 1.0000 |
| 13:57147693:G:GT | donor_gain | 0.9900 |
| 13:57147854:A:AG | acceptor_gain | 0.9900 |
| 13:57147855:G:GA | acceptor_gain | 0.9900 |
| 13:57147855:GC:G | acceptor_gain | 0.9900 |
| 13:57147855:GCC:G | acceptor_gain | 0.9900 |
| 13:57147855:GCCC:G | acceptor_gain | 0.9900 |
| 13:57147855:GCCCC:G | acceptor_gain | 0.9900 |
| 13:57148807:A:T | donor_gain | 0.9900 |
| 13:57148946:A:AG | acceptor_gain | 0.9900 |
| 13:57148947:G:GG | acceptor_gain | 0.9900 |
| 13:57147693:G:T | donor_gain | 0.9800 |
| 13:57147852:CCAGC:C | acceptor_loss | 0.9800 |
| 13:57147854:A:AT | acceptor_loss | 0.9800 |
| 13:57147855:G:GG | acceptor_gain | 0.9800 |
| 13:57147923:CAAG:C | donor_loss | 0.9800 |
| 13:57147924:AAGG:A | donor_loss | 0.9800 |
| 13:57147925:AGGTA:A | donor_loss | 0.9800 |
| 13:57147926:GGTAC:G | donor_loss | 0.9800 |
| 13:57147928:T:A | donor_loss | 0.9800 |
| 13:57148943:TTTA:T | acceptor_loss | 0.9800 |
| 13:57148947:G:GC | acceptor_loss | 0.9800 |
| 13:57148947:GCCT:G | acceptor_gain | 0.9800 |
| 13:57148947:GCCTC:G | acceptor_gain | 0.9800 |
| 13:57148858:C:CG | donor_gain | 0.9700 |
| 13:57148858:C:G | donor_gain | 0.9700 |
| 13:57148947:GCC:G | acceptor_gain | 0.9700 |
| 13:57148947:GC:G | acceptor_gain | 0.9600 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1086355 (13:57148789 A>T), RS1157229518 (13:57148460 C>A,T), RS1158550696 (13:57148628 C>A,G,T), RS1160772398 (13:57146441 C>T), RS1165831361 (13:57147841 T>A), RS1166108000 (13:57148034 C>G,T), RS1167027556 (13:57146034 C>T), RS1170901620 (13:57148348 T>C), RS1172000050 (13:57147858 C>T), RS1172395344 (13:57146295 C>A,G,T), RS1174313215 (13:57148359 T>C), RS1175138673 (13:57148468 C>G,T), RS1176584268 (13:57146564 C>G), RS1177755042 (13:57146382 C>A,T), RS1179205777 (13:57148276 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009066_26 | Mosaic loss of chromosome Y (Y chromosome dosage) | 8.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007783 | mosaic loss of chromosome Y measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.